Incretin and islet hormonal responses to fat and protein ingestion in healthy men.
Glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) regulate islet function after carbohydrate ingestion. Whether incretin hormones are of importance for islet function after ingestion of noncarbohydrate macronutrients is not known. This study therefore examined integrated incretin and islet hormone responses to ingestion of pure fat (oleic acid; 0.88 g/kg) or protein (milk and egg protein; 2 g/kg) over 5 h in healthy men, aged 20-25 yr (n=12); plain water ingestion served as control. Both intact (active) and total GLP-1 and GIP levels were determined as was plasma activity of dipeptidyl peptidase-4 (DPP-4). Following water ingestion, glucose, insulin, glucagon, GLP-1, and GIP levels and DPP-4 activity were stable during the 5-h study period. Both fat and protein ingestion increased insulin, glucagon, GIP, and GLP-1 levels without affecting glucose levels or DPP-4 activity. The GLP-1 responses were similar after protein and fat, whereas the early (30 min) GIP response was higher after protein than after fat ingestion (P<0.001). This was associated with sevenfold higher insulin and glucagon responses compared with fat ingestion (both P<0.001). After protein, the early GIP, but not GLP-1, responses correlated to insulin (r(2)=0.86; P=0.0001) but not glucagon responses. In contrast, after fat ingestion, GLP-1 and GIP did not correlate to islet hormones. We conclude that, whereas protein and fat release both incretin and islet hormones, the early GIP secretion after protein ingestion may be of primary importance to islet hormone secretion.
Carr
Richard D
RD
Novo Nordisk, Bagsvaerd, Denmark.
Larsen
Marianne O
MO
Winzell
Maria Sörhede
MS
Jelic
Katarina
K
Lindgren
Ola
O
Deacon
Carolyn F
CF
Ahrén
Bo
B
D000328:Adult; D001786:Blood Glucose / Q000378:metabolism; D001834:Body Water / Q000378:metabolism; D004032:Diet; D004041:Dietary Fats / Q000494:pharmacology*; D004044:Dietary Proteins / Q000494:pharmacology*; D018819:Dipeptidyl Peptidase 4 / Q000097:blood; D005230:Fatty Acids, Nonesterified / Q000097:blood; D005749:Gastric Inhibitory Polypeptide / Q000096:biosynthesis; D005934:Glucagon / Q000097:blood; D052216:Glucagon-Like Peptide 1 / Q000096:biosynthesis; D006801:Humans; D054795:Incretins / Q000096:biosynthesis*; D007328:Insulin / Q000097:blood; D007515:Islets of Langerhans / Q000187:drug effects* / Q000378:metabolism*; D008297:Male; D010187:Pancreatic Hormones / Q000378:metabolism*; D014280:Triglycerides / Q000097:blood
D001786:Blood Glucose; D004041:Dietary Fats; D004044:Dietary Proteins; D005230:Fatty Acids, Nonesterified; D054795:Incretins; D007328:Insulin; D010187:Pancreatic Hormones; D014280:Triglycerides; D005749:Gastric Inhibitory Polypeptide; D052216:Glucagon-Like Peptide 1; D005934:Glucagon; D018819:Dipeptidyl Peptidase 4